Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001099910-24-000316
Filing Date
2024-09-12
Accepted
2024-09-12 09:46:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g.htm SC 13G 74754
  Complete submission text file 0001099910-24-000316.txt   76067
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Subject) CIK: 0001858685 (see all company filings)

EIN.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93395 | Film No.: 241294068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 608-25 ST MARY STREET TORONTO Z4 M4Y1R2
Business Address
Saad Nabil (Filed by) CIK: 0002036497 (see all company filings)

Type: SC 13G